Ian Lewis

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

Ruth Ladenstein, Ulrike Pötschger, Marie‐Cécile Le Deley et al. · Journal of Clinical Oncology · 2010 · 539 citations · Full text

Medicine, Oncology, Surgery +11

Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

Ian Lewis, M. Nooij, Jeremy Whelan et al. · JNCI Journal of the National Cancer Institute · 2007 · 347 citations · Full text

Medicine, Oncology, Surgery +16

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

Andrew D.J. Pearson, CR Pinkerton, Ian Lewis et al. · The Lancet Oncology · 2008 · 341 citations

Medicine, Oncology, Chemotherapy +3

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial

Christine Juergens, Claire Weston, Ian Lewis et al. · Pediatric Blood & Cancer · 2006 · 280 citations

Pharmacy, Oncology, Pharmacotherapy +14

Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients

Michael Paulussen, Alan Craft, Ian Lewis et al. · Journal of Clinical Oncology · 2008 · 265 citations · Full text

Medicine, Oncology, Pharmacotherapy +14